Boston Scientific (NYSE:BSX) Given New $101.00 Price Target at Canaccord Genuity Group
Boston Scientific (NYSE:BSX – Get Free Report) had its price target upped by equities researchers at Canaccord Genuity Group from $98.00 to $101.00 in a research report issued on Monday,Benzinga ...
American Association of Individual Investors1 日
Which Is a Better Investment, Baxter International Inc. or Boston Scientific Corporation Stock?
or Boston Scientific Corporation because you’re not sure how they measure up ... and devices to treat neurological movement ...